Traynor Capital Management’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-49,263
Closed -$384K – 217
2022
Q4
$384K Sell
49,263
-7,312
-13% -$53.3K 0.05% 136
2022
Q3
$362K Sell
56,575
-3,525
-6% -$27.2K 0.06% 113
2022
Q2
$456K Buy
+60,100
New +$472K 0.08% 98
2020
Q3
– Sell
-50,500
Closed -$285K – 156
2020
Q2
$285K Buy
50,500
+14,000
+38% +$72.9K 0.07% 119
2020
Q1
$165K Buy
+36,500
New +$282K 0.06% 119
2019
Q1
– Sell
-15,215
Closed -$117K – 175
2018
Q4
$117K Sell
15,215
-628
-4% -$5.06K 0.05% 146
2018
Q3
$135K Sell
15,843
-2,125
-12% -$19.7K 0.04% 179
2018
Q2
$171K Sell
17,968
-2,679
-13% -$29K 0.06% 177
2018
Q1
$233K Hold
20,647
– – 0.09% 147
2017
Q4
$215K Buy
20,647
+1,450
+8% +$14.1K 0.09% 154
2017
Q3
$189K Sell
19,197
-82
-0.4% -$813 0.09% 149
2017
Q2
$198K Sell
19,279
-2,470
-11% -$25.2K 0.1% 143
2017
Q1
$223K Sell
21,749
-7,608
-26% -$81.8K 0.12% 132
2016
Q4
$309K Buy
+29,357
New +$277K 0.2% 92
2016
Q3
– Sell
-26,945
Closed -$182K – 127
2016
Q2
$182K Buy
+26,945
New +$242K 0.14% 115

Other funds holding BCS

Traynor Capital Management's BCS Position: Q1 2023 in Review

Traynor Capital Management sold out of Barclays (BCS) in Q1 2023, closing a stake of 49,263 shares — an estimated $384K sold.

Traynor Capital Management first reported a position in BCS in Q2 2016 and held it in 15 quarters. The position peaked at $456K in Q2 2022. 286 funds tracked by Wall St. Rank hold BCS as of Q1 2023.

  • Traynor Capital Management reported no remaining Barclays position as of Q1 2023 after selling out during the quarter.
  • Traynor Capital Management sold 49,263 Barclays shares in Q1 2023, an estimated $384K.
  • Traynor Capital Management first reported a position in Barclays in Q2 2016 and held it in 15 quarters.
  • Traynor Capital Management's Barclays position peaked at $456K in Q2 2022.
  • 286 funds tracked by Wall St. Rank held Barclays as of Q1 2023.

Based on Traynor Capital Management's 13F filing for Q1 2023, filed 21 Apr 2023.